The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen.

Because Delta-9-tetrahydrocannabinol (THC) inhibited luteinizing hormone-releasing hormone (LHRH) in male rats, we hypothesized that the endocannabinoid, anandamide (AEA), would act similarly. AEA microinjected intracerebroventricularly (i.c.v.) decreased plasma luteinizing hormone (LH) at 30 min in comparison to values in controls (P < 0.001). The cannabinoid receptor 1 (CB1-r)-specific antagonist, [N-(piperidin-1-yl)-1-(2,4-dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide] (AM251), produced a significant elevation in plasma LH (P < 0.01). AEA (10(-9) M) decreased LHRH release from medial basal hypothalami incubated in vitro. These results support the concept that endogenous AEA inhibits LHRH followed by decreased LH release in male rats. In ovariectomized (OVX) female rats, AEA i.c.v. also inhibited LH release, but in this case AM251 had an even greater inhibitory effect than AEA. In vitro, AEA had no effect on LHRH in OVX rats. It seems that endogenous AEA inhibits LHRH followed by decreased LH release in OVX rats but that AM251 has an inhibitory action in this case. In striking contrast, in OVX, estrogen-primed (OVX-E) rats, AEA i.c.v. instead of decreasing LH, increased its release. This effect was completely blocked by previous injection of AM251. When medial basal hypothalami of OVX-E rats were incubated, AEA increased LHRH release. The synthesized AEA was higher in OVX-E rats than in OVX and males, indicating that estrogen modifies endocannabinoid levels and effects. The results are interpreted to mean that sex steroids have profound effects to modify the response to AEA. It inhibits LHRH and consequently diminishes LH release in males and OVX females, but stimulates LHRH followed by increased LH release in OVX-E-primed rats.

[1]  A. Franchi,et al.  Alcohol inhibits luteinizing hormone-releasing hormone release by activating the endocannabinoid system. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Mccann,et al.  The effect of anandamide on prolactin secretion is modulated by estrogen , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Pistis,et al.  Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study , 2002, Brain Research.

[4]  M. Candolfi,et al.  Lipopolysaccharide- and Tumor Necrosis Factor-α-Induced Changes in Prolactin Secretion and Dopaminergic Activity in the Hypothalamic-Pituitary Axis , 2002, Neuroimmunomodulation.

[5]  T. Wenger,et al.  The role of endocannabinoids in the hypothalamic regulation of visceral function. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[6]  R. Pertwee,et al.  Cannabinoid receptors and their ligands , 2002, European Neuropsychopharmacology.

[7]  C. Ledent,et al.  The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. , 2001, Biochemical and biophysical research communications.

[8]  R. Nicoll,et al.  Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses , 2001, Nature.

[9]  D. Selley,et al.  Inhibitory effects of SR141716A on G-protein activation in rat brain. , 2001, European journal of pharmacology.

[10]  B. O’Malley,et al.  Progesterone receptor and dopamine receptors are required in Delta 9-tetrahydrocannabinol modulation of sexual receptivity in female rats. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Berry,et al.  Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. , 2000, European journal of pharmacology.

[12]  A. Lomniczi,et al.  Inhibitory pathways and the inhibition of luteinizing hormone-releasing hormone release by alcohol. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Wenger,et al.  Immunocytochemical Demonstration of CB1 Cannabinoid Receptors in the Anterior Lobe of the Pituitary Gland , 1999, Journal of neuroendocrinology.

[14]  G. Cabral,et al.  The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. , 1999, The Journal of pharmacology and experimental therapeutics.

[15]  A. Makriyannis,et al.  Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs. , 1998, Biochemical pharmacology.

[16]  J. Ramos,et al.  The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake. , 1997, Life sciences.

[17]  P. Casellas,et al.  A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1 , 1997, The Journal of Biological Chemistry.

[18]  J. Brotchie,et al.  Activation of the cannabinoid receptor by Δ9-tetrahydrocannabinol reduces γ-aminobutyric acid uptake in the globus pallidus , 1996 .

[19]  N. Volkow,et al.  123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. , 1996, European journal of pharmacology.

[20]  S. Mccann,et al.  Nitric oxide inhibits hypothalamic luteinizing hormone-releasing hormone release by releasing gamma-aminobutyric acid. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  B. O’Malley,et al.  Nitric oxide mediates sexual behavior in female rats. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Mackie,et al.  Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[24]  G. Snyder,et al.  Effects of delta-9-tetrahydrocannabinol on the hypothalamic-pituitary control of luteinizing hormone and follicle-stimulating hormone secretion in adult male rats. , 1987, Neuroendocrinology.

[25]  G. Fink,et al.  Endogenous GABA receptor ligands in hypophysial portal blood. , 1983, Neuroendocrinology.

[26]  J. Heid,et al.  Determination of GAB A Levels by a [3H]Muscimol Radioreceptor Assay , 1980, Journal of neurochemistry.

[27]  S. Ojeda,et al.  Catecholaminergic modulation of luteinizing hormone-releasing hormone release by median eminence terminals in vitro. , 1979, Endocrinology.

[28]  T. O'donohue,et al.  Effects of estrogen and progesterone on plasma gonadotropins and on catecholamine levels and turnover in discrete brain regions of ovariectomized rats , 1978, Brain Research.

[29]  S. Ojeda,et al.  A rapid and simple procedure for chronic cannulation of the rat jugular vein. , 1974, Journal of applied physiology.

[30]  A. Franchi,et al.  Mechanisms of inhibition of LHRH release by alcohol and cannabinoids. , 2002, Progress in brain research.

[31]  B. Marks.  Δ1-Tetrahydrocannabinol and Luteinizing Hormone Secretion , 1973 .

[32]  L. Pellegrino,et al.  stereotaxic atlas of the rat brain , 1967 .